XML 67 R38.htm IDEA: XBRL DOCUMENT v2.4.0.8
Segment Performance Based on Income (Loss) before Interest Income and Other Income and Expense (Detail) (USD $)
In Thousands, unless otherwise specified
3 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Segment Reporting Information [Line Items]    
Revenue $ 168,837 $ 202,467
Depreciation and amortization 5,954 2,372
Segment operating income (loss) 25,920 82,904
Molecular Diagnostics
   
Segment Reporting Information [Line Items]    
Revenue 164,507 192,987
Depreciation and amortization 4,978 1,362
Segment operating income (loss) 45,083 97,746
Pharmaceutical and Clinical Services
   
Segment Reporting Information [Line Items]    
Revenue 4,330 9,480
Depreciation and amortization 449 500
Segment operating income (loss) (1,782) 1,838
Research
   
Segment Reporting Information [Line Items]    
Depreciation and amortization 527 510
Segment operating income (loss) $ (17,381) $ (16,680)